Skip to main content

Published locations for Sitagliptin Performs Well in Early Studies : Novel compound significantly reduces glucose and is well tolerated in patients with type 2 diabetes.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Sitagliptin Performs Well in Early Studies : Novel compound significantly reduces glucose and is well tolerated in patients with type 2 diabetes.

User login

  • Reset your password
  • /content/sitagliptin-performs-well-early-studies-novel-compound-significantly-reduces-glucose-and
  • /familypracticenews/article/26548/endocrinology/sitagliptin-performs-well-early-studies-novel
  • /familymedicine/article/26548/endocrinology/sitagliptin-performs-well-early-studies-novel-compound